wydrukuj poleć znajomym zamów materiały
Od ilu lat pracuje Pani/Pan na różnych stanowiskach menedżerskich:

powyżej 20 lat
powyżej 15 lat
powyżej 10 lat
powyżej 5 lat
poniżej 5 lat
jeszcze nie byłam/-em menedżerem
nie chcę być menedżerem


Subskrypcja najnowszych ofert pracy





Nasi partnerzy:

rp.pl
gazeta.pl
onet.pl
interia.pl
wp.pl

Medtronic Acquires Advanced Uro-Solutions. Medtronic EVP & President Michael J. Coyle to Speak at Cowen Healthcare Conference 2015.02.28

Dublin, Ireland - February 27, 2015 - Medtronic plc (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Cowen and Company 35th Annual Healthcare Conference in Boston. Michael J. Coyle, executive vice president and president of Medtronic's Cardiac and Vascular Group, will make a presentation about Medtronic on Tuesday, March 3, 2015, beginning at 11:20 a.m. EST (10:20 a.m. CST). Medtronic plc announced that it has acquired Advanced Uro-Solutions, a privately-held developer of neurostimulation products for the treatment of bladder control issues based in Elizabethton, Tennessee, USA. Advanced Uro-Solutions develops and manufactures the NURO(TM) percutaneous tibial nerve stimulation system, which consists of a small external stimulator and a single, reusable lead to provide temporary stimulation to the tibial nerve. This therapy is 510(k) cleared by the FDA to treat patients with overactive bladder (OAB) and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Medtronic is preparing to launch the NURO system in the U.S. within the next 12 months.

Medtronic plc, headquartered in Dublin, Ireland, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.
Photo courtesy of Medtronic
 

Dublin, Ireland - February 27, 2015

Medtronic plc (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Cowen and Company 35th Annual Healthcare Conference in Boston.

Michael J. Coyle, executive vice president and president of Medtronic's Cardiac and Vascular Group, will make a presentation about Medtronic on Tuesday, March 3, 2015, beginning at 11:20 a.m. EST (10:20 a.m. CST).

Photo courtesy of Medtronic
 
A live audio webcast of the presentation will be available on March 3, 2015, by clicking on the Investors link on the Medtronic home page at
http://www.medtronic.com 

Medtronic Acquires Advanced Uro-Solutions


NURO Percutaneous Tibial Nerve Stimulation System to Enhance Neuromodulation Product Offerings for Treatment of Bladder Control Issues

Dublin, Ireland - February 23, 2015 - Medtronic plc (NYSE: MDT) today announced that it has acquired Advanced Uro-Solutions, a privately-held developer of neurostimulation products for the treatment of bladder control issues based in Elizabethton, Tennessee, USA.

Terms of the acquisition agreement, which closed in December 2014, were not disclosed.

Photo courtesy of Medtronic
 
Advanced Uro-Solutions develops and manufactures the NURO(TM) percutaneous tibial nerve stimulation system, which consists of a small external stimulator and a single, reusable lead to provide temporary stimulation to the tibial nerve.

 
 
This therapy is 510(k) cleared by the FDA to treat patients with overactive bladder (OAB) and associated symptoms of urinary urgency, urinary frequency and urge incontinence.

Medtronic is preparing to launch the NURO system in the U.S. within the next 12 months.

More than 37 million adults in the United States - one in six - suffer from OAB.1,2 By 2018, it is estimated that 546 million people worldwide will be affected by OAB.3

Photo courtesy of Medtronic
 
"The acquisition of Advanced Uro-Solutions expands Medtronic's portfolio of treatment options for those suffering from chronic symptoms of overactive bladder,"
said Linnea Burman, vice president and general manager, gastro/urology therapies at Medtronic
.
"Medtronic continues to invest in fully-implantable bladder control and bowel control therapies, and the addition of the NURO system to our existing portfolio of products will introduce more people suffering from bladder control issues to the benefits of neuromodulation."

Courtesy of Medtronic
 
Since 2009, Advanced Uro-Solutions has been led by two founders, Dr. Brent Laing and Dr. John Green.


Courtesy of Medtronic
 
"Studies show that roughly 80 percent of patients prescribed oral medications to treat their OAB symptoms have stopped taking them at 12 months, and Medtronic shares our commitment to advancing neuromodulation and increasing patient access to advanced solutions intended to treat their symptoms,"
said Dr. John Green, former chairman and CEO of Advanced Uro-Solutions.
"We are excited to take this step toward making this important therapy available to patients around the world."

Courtesy of Medtronic
 
Medtronic developed and leads the field of neuromodulation, the targeted and regulated delivery of electrical pulses and pharmaceuticals to specific sites in the nervous system.

The company's Neuromodulation division includes implantable neurostimulation and targeted drug delivery systems for the management of chronic pain, common movement disorders, spasticity and urologic and gastrointestinal disorders.

Courtesy of Medtronic
 
Medtronic will include revenue from the Advanced Uro-Solutions product line as part of the Neuromodulation division within the Restorative Therapies Group segment.

Courtesy of Medtronic
 
The transaction is expected to meet Medtronic's long-term financial metrics, and the annualized earnings impact of this acquisition is not expected to be material.


Courtesy of Medtronic
 

About Medtronic


Medtronic plc ( www.medtronic.com ), headquartered in Dublin, Ireland, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.

 
 
Overview


Our businesses fall into three main groups at Medtronic:

1. Cardiac and Vascular Group (CVG): $8.8 Billion

2. Restorative Therapies Group (RTG): $6.5 Billion

3. Diabetes Group (DG): $1.7 Billion


FY2014 Revenue by Business (in millions), Medtronic plc
Courtesy of Medtronic
 
Product Leadership

With its expanded portfolio of innovative products and services, Medtronic is a preeminent leader in delivering therapy and procedural innovations to address the major disease states impacting patients and healthcare costs around the world.

The acquisition of Covidien brought an impressive portfolio of industry-leading products that enhance Medtronic’s existing portfolio, offer greater breadth across clinical areas, or create exciting entry points into new therapies.

Photo courtesy of Medtronic
 
The combined company offers pioneering therapy innovations across a broad range of areas including
:

1. Transcatheter valves
2. Peripheral vascular therapies
3. Pacing systems
4. Predictive cardiac diagnostics
5. Virtual pancreas
6. Stroke therapies
7. Advanced energy products
8. Bariatric surgery
9. Minimally invasive and assisted surgery
10. Lung and GI cancer diagnostics and therapy

Photo courtesy of Medtronic
 
Medical device categories

Between Medtronic and Covidien, we are number one in 12 medical device categories, including:

1. Cardiac rhythm disease management
2. Coronary stents
3. Diabetes
4. Endovascular
5. Medical supplies (U.S.)
6. Minimally invasive surgery
7. Neuromodulation
8. Neurovascular
9. Peripheral vascular
10. Respiratory and monitoring
11. Spine
12. Surgical technologies


Photo courtesy of Medtronic
 
More Information:


ASTROMAN Magazine - 2014.06.20

Medtronic to Acquire Covidien for $42.9 billion in Cash and Stock

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1739  


Courtesy of Medtronic
 

Contacts:

Justin Ihle
Public Relations
+1-763-526-0911

Jeff Warren
Investor Relations
+1-763-505-2696


Medtronic plc, headquartered in Dublin, Ireland, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.
Photo courtesy of Medtronic
 
Video
The Medtronic Journey

https://www.youtube.com/watch?v=wCb50q0NNag  


Video
Medtronic At A Glance

https://www.youtube.com/watch?v=HPTgaHb8pSw  



Michael Coyle

Executive Vice President and Group President, Cardiac and Vascular Group

Michael J. Coyle
Photo courtesy of Medtronic
 
Michael J. Coyle was named Executive Vice President and Group President for the Medtronic’s Cardiac Rhythm Heart Failure (CRHF), Coronary and Structural Heart (CSH), and Aortic and Peripheral Vascular (APV) business units in December 2009
.
In this role, Mike oversees three Medtronic businesses, providing strategic direction, and ensuring cross-functional synergies including integrated growth plans and alignment.

Prior to joining Medtronic, Mike most recently provided leadership consulting services to private equity, venture capital and medical device technology firms.

From 2001 to 2007, he served as President of the CRM division at St. Jude Medical where he led the company’s global pacemaker, implantable cardioverter defibrillator, and cardiac resynchronization businesses.

He also served St. Jude as President of the company’s Daig Catheter division.
In addition, Mike has held numerous leadership positions at Eli Lilly & Company.

He earned a bachelor’s degree from Case Western Reserve University and a master’s degree in business administration from the Wharton School of Business, University of Pennsylvania.


Source: Medtronic plc

http://newsroom.medtronic.com/  



ASTROMAN Magazine - 2015.02.04

World Cancer Day: The Road Ahead for Cervical Cancer Screening

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1877  


ASTROMAN Magazine - 2014.12.21

Philips to acquire Volcano to expand global leadership position in image-guided therapy market for USD 1.2 billion

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1850  


ASTROMAN Magazine - 2014.12.20

ElectRx Has the Nerve to Envision Revolutionary Therapies for Self-Healing

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1848  


ASTROMAN Magazine - 2014.11.22

Poland's NCBJ thermal-to-14 MeV neutron converter is a sole device of its kind operated in the world

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1834  


ASTROMAN Magazine - 2014.11.10

Siemens to sell hearing aid business to EQT and Struengmann family for EUR2.15 Billion

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1827  


ASTROMAN Magazine - 2014.08.30

IBM Watson Ushers in a New Era of Data-Driven Discoveries

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1783  


ASTROMAN Magazine - 2014.06.20

Medtronic to Acquire Covidien for $42.9 billion in Cash and Stock

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1739  


ASTROMAN Magazine - 2014.06.08

Fujitsu World Tour 2014 w Warszawie czyli Fujitsu buduje hiperpołączony świat

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1727  


ASTROMAN Magazine - 2013.12.15

Boston Dynamics:  Changing Your Idea of What Robots Can Do

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1606  


ASTROMAN Magazine - 2013.11.16

IBM Watson's Next Venture: Fueling New Era of Cognitive Apps Built in the Cloud by Developers

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1587  


ASTROMAN Magazine - 2013.10.06

Philips collaborates with Accenture to create first proof of concept for delivering vital patient data via Google Glass

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1565  


ASTROMAN Magazine - 2013.09.08

Philips presents latest 'digital' consumer innovations at IFA in Berlin

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1551  


ASTROMAN Magazine - 2013.09.01

Philips showcases innovations in cardiology at European Society of Cardiology Congress 2013

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1542  


ASTROMAN Magazine - 2013.09.01

Fujitsu Develops World's First Homomorphic Encryption Technology that Enables Statistical Calculations and Biometric Authentication

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1540  


ASTROMAN Magazine - 2013.08.16

HealthInterlink Joins Alcatel-Lucent's ng Connect Program for Beacon Clinical Care Access

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1516  


ASTROMAN Magazine – 2013.08.10

Fujitsu and Microsoft Japan to Equip Meiji Yasuda Life Insurance's 30,000 Advisors

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1513  


ASTROMAN Magazine – 2013.05.19

Fujitsu Semiconductor Develops World's First 360° Wraparound View System with Approaching Object Detection

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1465  


ASTROMAN Magazine – 2012.08.26

New era for interventional cardiologists as GE Healthcare's Discovery is CE Marked

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1302  


ASTROMAN Magazine – 2012.06.08

GE Healthcare and Philips Healthcare Commend FCC Rule for Wireless Medical Sensor Technologies

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1253  


ASTROMAN Magazine – 2012.06.07

Microsoft and General Electric Healthcare Complete Joint Venture Agreement for new company Caradigm

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1250  


ASTROMAN Magazine – 2012.04.22

GE Healthcare to Develop Next Generation Compact Cyclotron and PET Tracer System for Global Markets

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1224  


ASTROMAN Magazine – 2012.04.14

Dolby and Philips Unveil 3D HD Format Capable of Bringing Full HD 3D to Glasses-Free 3D Devices

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1219  


ASTROMAN Magazine – 2012.03.18

Philips and the World Association of Sleep Medicine join together to raise global awareness of the importance of sleep

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1206  


ASTROMAN Magazine – 2012.03.03

IBM Forms Watson Healthcare Advisory Board

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1191  


ASTROMAN Magazine – 2012.02.12

Philips and Catharina Hospital collaborate to highlight innovation in heart rhythm disorder treatment

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1176  


ASTROMAN Magazine – 2011.12.26

Philips and VU University Medical Center Amsterdam sign agreement for PET/MR scanner

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1131  


ASTROMAN Magazine – 2011.12.11

GE, Microsoft to Launch Joint Venture Aimed at Global Healthcare System Transformation

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1117  


ASTROMAN Magazine – 2011.12.04

GE Healthcare Taps Global Industry Leader to Head Magnetic Resonance Business

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1113  


ASTROMAN Magazine – 2011.10.04

GE Healthcare Spotlights its Commitment to Advancing Cancer Care at ASTRO 2011

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1071  


ASTROMAN Magazine – 2011.09.18

GE Healthcare to Invest $1 Billion in New Oncology Solutions

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1060  


ASTROMAN Magazine – 2011.07.11

GE Healthcare Wins Design Excellence Awards for Magnetic Resonance Imaging

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=1017  


ASTROMAN Magazine – 2011.06.04

GE Healthcare Opens Life Sciences Demonstration Laboratory in Stockholm, Sweden

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=986  


ASTROMAN Magazine – 2011.02.23

Philips and Microsoft Collaborate to Streamline Radiology Workflow and Processes

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=902  


ASTROMAN Magazine – 2011.02.20

IBM to Collaborate with Nuance to Apply IBM's "Watson" Analytics Technology to Healthcare

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=899  


ASTROMAN Magazine - 2011.01.23

Siemens Healthcare unveils the world's first integrated whole-body molecular MR system available for clinical use

http://www.astroman.com.pl/index.php?mod=magazine&a=read&id=887  



Editor-in-Chief of ASTROMAN magazine: Roman Wojtala, PhD.


wydrukuj ten artykuł
  strona: 1 z 1
polecamy artykuły
NASA, Northrop Grumman Launch Space Station, National Lab Cargo
Dell EMC Gains High Performance Computing Momentum and Expands Portfolio
Fourth industrial revolution and machine learning
NASA TV Coverage Set for November 15 Cygnus Launch to International Space Station
Daimler and Bosch: San José as the pilot city for automated ride-hailing service
Intel Shows Breadth of Data-Centric Platform with Cascade Lake Advanced Performance and Xeon E-2100
Intel Shows Breadth of Data-Centric Platform with Cascade Lake Advanced Performance
A window to the cloud: Microsoft unveils new Azure Cloud Collaboration Center
IBM Blockchain: How Dubai is Becoming the Blockchain Capital of the World
IBM To Acquire Red Hat, Completely Changing The Cloud Landscape And Becoming World's #1 Hybrid Cloud Provider For USD34 Billion
Lockheed Martin: U.S. Army Pilots Fly Autonomous Sikorsky Helicopter In First-Of-Its-Kind Demonstration
Lockheed Martin: Aegis Combat System Demonstrates Success During At-Sea Test Against Medium Range Ballistic Missile
Prof. Witold M. Orłowski: Polska 2050. Warunki rozwoju naszego kraju
Prof. Grzegorz W. Kołodko: Miejsce Polski w szeregu państw świata
Emirates: Miracle Garden w Dubaju czyli Morze kwiatów na środku pustyni
strona główna  |  oferty pracy  |  executive search  |  ochrona prywatności  |  warunki używania  |  kontakt     RSS feed subskrypcja RSS
Copyright ASTROMAN © 1995-2018. Wszelkie prawa zastrzeżone.
Projekt i wykonanie: TAU CETI.